Our in vivo data also provides strong evidence that EGFR-phosphorylated PFKP Y64 can induce expression levels of HIF-1α, β-catenin S552 phosphorylation, and VEGF, leading to enhanced vascularization of tumors in the GBM xenograft. This evidence concerns the gene EGFR and glioblastoma.